Phathom Pharmaceuticals
PHAT
PHAT
84 hedge funds and large institutions have $220M invested in Phathom Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 87 → 84 (-3)
31% less capital invested
Capital invested by funds: $317M → $220M (-$96.9M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
84
Holding in Top 10
2
Calls
$1.81M
Puts
$16K
Top Buyers
| 1 | +$20.9M | |
| 2 | +$1.7M | |
| 3 | +$1.43M | |
| 4 |
NM
Newtyn Management
New York
|
+$1.41M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.34M |
Top Sellers
| 1 | -$2.64M | |
| 2 | -$1.64M | |
| 3 | -$657K | |
| 4 |
BlackRock
New York
|
-$439K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$185K |